Nasal polyp patients may finally ditch pricey biologics
NCT ID NCT07268313
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether people with severe nasal polyps who have been symptom-free for at least a year on biologic drugs like Dupixent or Nucala can safely stop taking them. 66 participants will either stop their medication or continue as usual, and researchers will track if they stay well. The goal is to see if long-term control is possible without ongoing treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dept. of otorhinolaryngology, Odense
RECRUITINGOdense, Region Syd, 5000, Denmark
-
Gødstrup Hospital
RECRUITINGGødstrup, Denmark
-
Køge øre næse hals afd
RECRUITINGKøge, Region Sj, 4600, Denmark
-
Nordsjællands hospital
RECRUITINGHillerød, Region H, 3400, Denmark
-
Rigshospitalet
RECRUITINGCopenhagen, Region H, 2100, Denmark
-
Vejle sygehus
RECRUITINGVejle, Region S, 7100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an asthma drug shrink nasal polyps? a major trial seeks answers
- Can a single drug shrink nasal polyps and restore breathing?
- Nanoparticle steroid spray could transform recovery after sinus surgery
- Could a single biologic replace steroid sprays for nasal polyps?
- New study tests tezepelumab for chronic sinusitis sufferers
- New biologics offer hope for severe nasal polyps sufferers